A substantial number of patients with head and neck squamous cell carcinoma (SCC) present with metastatic regional disease. In fact, head and neck SCC arising from the oropharynx has clinically positive nodes in more than 50% of patients, and 30% to 40% of patients with clinically negative necks harbor occult disease in the neck.
1 Human papillomavirus (HPV) has emerged as a risk factor for cancers of the oropharynx, with up to 50% of tonsil cancers testing positive for HPV.
2-4 Patients with HPV-associated cancers have an improved overall and disease-specific survival.
5 Treatment of oropharyngeal SCC (OPSCC) with curative intent includes either surgery with or without adjuvant (chemo)radiation therapy or radiation therapy with or without chemotherapy.
6,7